ATE469660T1 - Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden - Google Patents

Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden

Info

Publication number
ATE469660T1
ATE469660T1 AT07803220T AT07803220T ATE469660T1 AT E469660 T1 ATE469660 T1 AT E469660T1 AT 07803220 T AT07803220 T AT 07803220T AT 07803220 T AT07803220 T AT 07803220T AT E469660 T1 ATE469660 T1 AT E469660T1
Authority
AT
Austria
Prior art keywords
gas
filled microvesicles
polymer
modified lipids
hydrophilic polymer
Prior art date
Application number
AT07803220T
Other languages
English (en)
Inventor
Stephane Gorgerat
Christian Guillot
Feng Yan
Original Assignee
Bracco Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Research Sa filed Critical Bracco Research Sa
Application granted granted Critical
Publication of ATE469660T1 publication Critical patent/ATE469660T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Tires In General (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
AT07803220T 2006-09-05 2007-09-04 Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden ATE469660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06120109 2006-09-05
PCT/EP2007/059256 WO2008028917A1 (en) 2006-09-05 2007-09-04 Gas-filled microvesicles with polymer-modified lipids

Publications (1)

Publication Number Publication Date
ATE469660T1 true ATE469660T1 (de) 2010-06-15

Family

ID=37834117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07803220T ATE469660T1 (de) 2006-09-05 2007-09-04 Gasgefüllte mikrovesikel mit polymer- modifizierten lipiden

Country Status (10)

Country Link
US (1) US9446156B2 (de)
EP (1) EP2061517B1 (de)
JP (1) JP5420410B2 (de)
CN (1) CN101528268B (de)
AT (1) ATE469660T1 (de)
AU (1) AU2007293888B2 (de)
CA (1) CA2662087C (de)
DE (1) DE602007006968D1 (de)
IL (1) IL197380A (de)
WO (1) WO2008028917A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2485976C2 (ru) * 2011-05-17 2013-06-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Контрастное средство для ультразвуковой визуализации
EP2875348B1 (de) 2012-07-19 2018-09-26 Atlantic Cancer Research Institute Verfahren zur isolierung von mikrovesikeln
TWI552761B (zh) 2013-05-03 2016-10-11 博信生物科技股份有限公司 一種脂質微／奈米氣泡、及其最佳化之製備方法及製備裝置
CN104353088A (zh) * 2014-09-30 2015-02-18 东南大学 一种脂质气泡的制备方法
EP3236999B1 (de) * 2014-12-22 2019-03-20 Bracco Suisse SA Gasgefüllte mikrovesikel zur verwendung als impfstoff
US9729782B2 (en) * 2015-06-05 2017-08-08 Digital Signal Corporation System and method for intelligent camera control
EP3395370B1 (de) * 2015-12-21 2021-01-20 FUJIFILM Corporation Liposom und liposomzusammensetzung
CN117919456A (zh) 2016-02-01 2024-04-26 博信生物科技股份有限公司 脂质微泡及其制备方法
RU2619353C1 (ru) * 2016-05-27 2017-05-15 государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СибГМУ Минздрава России) Газосодержащее контрастное средство для ультразвуковой диагностики
CA3120179A1 (en) * 2018-12-21 2020-06-25 Bracco Suisse Sa Gas-filled microvesicles with ligand
CN110272867B (zh) * 2019-07-25 2023-10-20 深圳博雅感知药业有限公司 用于细胞分选的链霉亲和素偶联微泡的液体制剂
CN110358731B (zh) * 2019-07-25 2023-11-10 深圳博雅感知药业有限公司 从外周血中直接分离目标细胞的方法
CN110272868B (zh) * 2019-07-25 2023-10-20 深圳博雅感知药业有限公司 制备用于细胞分选的链霉亲和素偶联微泡冻干制剂的方法
CN110272869B (zh) * 2019-07-25 2023-10-20 深圳博雅感知药业有限公司 细胞分选用链霉亲和素偶联微泡的冻干制剂和用途
CN111265675A (zh) * 2020-02-10 2020-06-12 上海市东方医院（同济大学附属东方医院） 一种用于标记间充质干细胞的超声微泡造影剂及其制备方法
CN114323863B (zh) * 2021-12-31 2023-12-22 吉林大学 一种外泌体阵列捕获探针的制备方法与应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
IN172208B (de) 1990-04-02 1993-05-01 Sint Sa
US5556610A (en) 1992-01-24 1996-09-17 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
US5445813A (en) 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5464696A (en) 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
EP0711179B2 (de) 1993-07-30 2010-09-01 IMCOR Pharmaceutical Co. Stabilisierte mikrogasblaeschen-zusammensetzungen für echografie
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
IL116328A (en) 1994-12-16 1999-09-22 Bracco Research Sa Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US5833948A (en) 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
CA2246778A1 (en) 1996-02-19 1997-08-21 Per Helge Gulliksen Thermally stabilized contrast agent
JP4418033B2 (ja) 1996-02-19 2010-02-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤のまたはそれに関する改良
US6261537B1 (en) * 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
BR9712683A (pt) * 1996-10-28 1999-10-19 Nyomed Imaging A S Agente de diagnóstico e/ou terapeuticamente ativo alvejável, formulação combinada, processo para preparação e uso do mesmo, formulação combinada, e processos para gerar imagens intensificadas de um corpo animal humano ou não-humano e para investigação in vitro de alvejamento por um agente.
WO1998018501A2 (en) 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
WO1999039738A1 (en) 1998-02-09 1999-08-12 Bracco Research S.A. Targeted delivery of biologically active media
GB9809084D0 (en) 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
JP2004512345A (ja) * 2000-11-02 2004-04-22 スミスクライン・ビーチャム・コーポレイション 受容体アンタゴニスト−脂質コンジュゲートおよびそれを含有するデリバリービヒクル
AU2002248222B2 (en) 2000-12-23 2006-04-27 Dyax Corp. Fibrin binding polypeptides useful inter alia in medical imaging processes
AU2003213730A1 (en) 2002-03-01 2003-09-16 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
WO2003084574A1 (en) 2002-03-01 2003-10-16 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2004069284A2 (en) 2003-02-04 2004-08-19 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
US20050025710A1 (en) * 2003-07-29 2005-02-03 Michel Schneider Reconstitutable formulation and aqueous suspension of gas-filled microvesicles for diagnostic imaging
JP5513708B2 (ja) 2003-12-22 2014-06-04 ブラッコ・シュイス・ソシエテ・アノニム 造影イメージング用の気体封入マイクロベシクル・アセンブリー
EP1696965B1 (de) 2003-12-22 2014-12-10 Bracco Suisse SA Anordnung aus gasgefüllten mikrovesikeln mit wirkstoff für die kontrastdarstellung
JP2006063052A (ja) * 2004-08-30 2006-03-09 Konica Minolta Medical & Graphic Inc リポソーム含有超音波造影剤およびその製造方法
AU2005332157A1 (en) 2005-05-23 2006-11-30 Mebiopharm Co., Ltd., Method of producing liposomes containing gas enclosed therein
CN1814305A (zh) * 2005-12-09 2006-08-09 重庆医科大学 载基因或药物的超声微泡造影剂及其制备方法

Also Published As

Publication number Publication date
AU2007293888B2 (en) 2013-05-02
US20090263330A1 (en) 2009-10-22
CA2662087C (en) 2015-01-06
CA2662087A1 (en) 2008-03-13
IL197380A (en) 2011-01-31
EP2061517B1 (de) 2010-06-02
AU2007293888A1 (en) 2008-03-13
JP5420410B2 (ja) 2014-02-19
WO2008028917A1 (en) 2008-03-13
DE602007006968D1 (de) 2010-07-15
EP2061517A1 (de) 2009-05-27
CN101528268A (zh) 2009-09-09
US9446156B2 (en) 2016-09-20
CN101528268B (zh) 2012-07-04
JP2010502671A (ja) 2010-01-28

Similar Documents

Publication Publication Date Title
DE602007006968D1 (de) Gasgefüllte mikrovesikel mit polymer-modifizierten lipiden
CY1123901T1 (el) Φαρμακευτικη συνθεση και χορηγησεις αυτης
CY1126136T1 (el) Μεθοδοι θεραπειας της αρθριτιδας
EP4241767A3 (de) Neuartige lipide und zusammensetzungen zur verabreichung von therapeutika
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
BRPI0608297A2 (pt) composições de lipossomos
EA200970651A1 (ru) Неспецифичные иммуностимулирующие агенты
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
WO2008109031A8 (en) Liposome carriers for in vivo delivery of fullerenes
WO2009086504A3 (en) Collagen formulations for improved skin care
CY1115664T1 (el) Επικαλυψεις απελευθερωσης φαρμακευτικης ουσιας για ιατρικες διαταξεις
RU2014141545A (ru) Нацеливающие аминокислотные липиды
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
MY153408A (en) Novel methods
ES2496669T3 (es) Agentes antitumorales con una estructura de benzofenantridina y formulaciones que los contienen
MX350870B (es) Formula para lactantes con alto palmitato sn-2 y oligofructosa.
CY1118457T1 (el) Χρηση εκχυλισματων απο δερμα κονικλου φλεγμαινοντος εκ του ιου δαμαλιτιδας για την παρασκευη φαρμακου για τη θεραπεια της οξειας αγγειακης εγκεφαλικης νοσου
ES2525066T3 (es) Uso terapéutico de preparaciones farmacéuticas que contienen fármacos antitumorales unidos a ácido hialurónico en el tratamiento de neoplasias
EP2359864A3 (de) Zielender Vektor-Phospholipid Konjugaten
Gao et al. A nano-strategy for advanced triple-negative breast cancer therapy by regulating intratumoral microbiota
MX2010001948A (es) Uso de nanotubo de carbono para el suministro de farmacos.
EP2294553A4 (de) Anzeige von zweidimensionalem inhalt während einer dreidimensionalen präsentation
EP4403220A3 (de) Effiziente lipidabgabe an einen menschlichen tränenfilm unter verwendung eines salzempfindlichen emulsionssystems
WO2009076388A3 (en) Targeting vector-phospholipid conjugates
Sánchez-Martín et al. A Langmuir Monolayer Study of the Interaction of E1 (145− 162) Hepatitis G Virus Peptide with Phospholipid Membranes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties